ArticleThe archives of bone and joint surgery2025
Mean Platelet Volume in Blood vs. Platelet-Rich Plasma: Demographic Analysis and Intrasubject Variability in PRP Therapy.
Article in The archives of bone and joint surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Intraosseous platelet-rich plasma for osteoarthritis: a comprehensive review.EFORT open reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate inter- and intraindividual differences in mean platelet volume (MPV) between blood and platelet-rich plasma (PRP), and to assess the influence of demographic factors (sex, age, body mass index (BMI)). Methods: A retrospective analysis of 877 patients treated with PRP for musculoskeletal conditions (Nov 2021-Dec 2024). MPV values in blood and PRP were compared. Intrasubject variability was analyzed in a subgroup of 298 patients who received at least three PRP doses. Results: MPV was significantly lower in PRP compared to blood (p < 0.001). Age, sex, and BMI had no significant effect on MPV. The coefficient of variation (CV) was low in both blood (2.78%) and PRP (3.87%), with the variation in PRP being significantly greater than that in blood (p < 0.001). Intrasubject MPV variability was low (coefficient of variation (CV): 2.78% in blood, 3.87% in PRP; p < 0.001), while intersubject variability was greater in PRP. Conclusion: Centrifugation significantly reduces MPV in PRP compared to whole blood, indicating that the preparation process alters platelet characteristics. While demographic factors such as age, sex, and BMI do not appear to influence platelet size, the greater intersubject variability-compared to low intrasubject variability-suggests that centrifugation protocols play a key role in determining PRP composition. These findings support the reliability of the single-step PRP preparation method used in this study and highlight the importance of protocol standardization to ensure consistent biological quality, which may ultimately impact the therapeutic effectiveness of PRP in musculoskeletal treatments.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.